Your browser doesn't support javascript.
loading
Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study.
Samkari, Mayada M; Bokhari, Neda'a S; Alhajaji, Raghad; Ahmed, Malaz E; Al Raddadi, Ahmad; Bahget, Alaa K; Saleh, Sarah F; Aljehani, Faisal; Alzahrani, Saud H; Alsifyani, Sarah S; Samkari, May M; Badr, Aisha F; Alalawi, Mai; Al Sulaiman, Khalid.
Afiliação
  • Samkari MM; Diabetic and Endocrine Center, Al-Noor Specialist Hospital, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Bokhari NS; Diabetic and Endocrine Center, Al-Noor Specialist Hospital, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Alhajaji R; Health Programs Administration, Makkah Health Affairs, Ministry of Health, Makkah, Saudi Arabia.
  • Ahmed ME; Al-Magrah Primary Health Care, Primary Care Administration, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Al Raddadi A; Health Programs Administration, Makkah Health Affairs, Ministry of Health, Makkah, Saudi Arabia.
  • Bahget AK; Diabetic and Endocrine Center, Al-Noor Specialist Hospital, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Saleh SF; Diabetic and Endocrine Center, Al-Noor Specialist Hospital, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Aljehani F; Diabetic and Endocrine Center, Al-Noor Specialist Hospital, Makkah Healthcare Cluster, Makkah, Saudi Arabia.
  • Alzahrani SH; College of Medicine, Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Alsifyani SS; Public Health Administration, Makkah Health Affairs, Ministry of Health, Makkah, Saudi Arabia.
  • Samkari MM; North Obhor PHC-Ministry of Health, Jeddah, Saudi Arabia.
  • Badr AF; Health Programs Administration, Jeddah Health Affairs, Ministry of Health, Jeddah, Saudi Arabia.
  • Alalawi M; Pharmacy Practice Department, King Abdulaziz University Faculty of Pharmacy, Jeddah, Saudi Arabia.
  • Al Sulaiman K; Department of Pharmaceutical Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Saudi Pharm J ; 31(6): 972-978, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37234349
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Saudi Pharm J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita